Cahill Represents Lead Arrangers in Acquisition Financing for Impax Laboratories
Date: 03/09/15
Cahill represented Barclays Bank as administrative agent and lead arranger, and Royal Bank of Canada and Wells Fargo Bank as lead arrangers in connection with a $435,000,000 Term B loan and a $50,000,000 revolving credit facility for Impax Laboratories, Inc., a technology-based specialty pharmaceutical company. Proceeds from the facility were in part used to finance the acquisition of Tower Holdings, Inc. and Lineage Therapeutics Inc., as well for general corporate purposes, and to refinance existing indebtedness.